Antisense Therapeutics Limited
ATHJF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12 | -$11 | -$6 | -$8 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$0 | -$0 | -$1 |
| Stock-Based Comp. | $0 | $0 | $0 | $1 |
| Change in WC | $2 | $3 | -$2 | $1 |
| Other Non-Cash | -$1 | $0 | $0 | $1 |
| Operating Cash Flow | -$10 | -$8 | -$8 | -$6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $11 | $0 | $23 | $9 |
| Stock Repurch. | $0 | $0 | -$1 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$0 |
| Financing Cash Flow | $11 | -$0 | $21 | $8 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$8 | $13 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11 | $19 | $6 | $4 |
| End Cash | $12 | $11 | $19 | $6 |
| Free Cash Flow | -$10 | -$8 | -$8 | -$6 |